Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
M Arbyn, L Xu - Expert review of vaccines, 2018 - Taylor & Francis
Introduction: Recently, the evidence on efficacy and safety of prophylactic HPV vaccines
derived from randomized trials was published in the Cochrane database of Systematic …
derived from randomized trials was published in the Cochrane database of Systematic …
[HTML][HTML] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …
[HTML][HTML] International standardization and classification of human papillomavirus types
D Bzhalava, C Eklund, J Dillner - Virology, 2015 - Elsevier
Abstract Established Human Papillomavirus (HPV) types, up to HPV202, belong to 49
species in five genera. International standardization in classification and quality standards …
species in five genera. International standardization in classification and quality standards …
[HTML][HTML] Human papillomavirus genomics: Understanding carcinogenicity
CW Nelson, L Mirabello - Tumour Virus Research, 2023 - Elsevier
Human papillomavirus (HPV) causes virtually all cervical cancers and many cancers at other
anatomical sites in both men and women. However, only 12 of 448 known HPV types are …
anatomical sites in both men and women. However, only 12 of 448 known HPV types are …
Are 20 human papillomavirus types causing cervical cancer?
M Arbyn, M Tommasino, C Depuydt… - The Journal of …, 2014 - Wiley Online Library
Abstract In 2012, the International Agency for Research on Cancer concluded that there was
consistent and sufficient epidemiological, experimental and mechanistic evidence of …
consistent and sufficient epidemiological, experimental and mechanistic evidence of …
VALGENT: a protocol for clinical validation of human papillomavirus assays
Background Testing for high-risk HPV is more effective in primary cervical cancer screening
than the cytological examination of a Pap smear. Separate genotyping may be useful for …
than the cytological examination of a Pap smear. Separate genotyping may be useful for …
Glycosaminoglycans in infectious disease
E Kamhi, EJ Joo, JS Dordick, RJ Linhardt - Biological Reviews, 2013 - Wiley Online Library
Glycosaminoglycans (GAGs) are complex carbohydrates that are ubiquitously present on
the cell surface and in the extracellular matrix. Interactions between GAGs and pathogens …
the cell surface and in the extracellular matrix. Interactions between GAGs and pathogens …
Human Beta‐papillomavirus infection and keratinocyte carcinomas
KD Quint, RE Genders, MNC De Koning… - The Journal of …, 2015 - Wiley Online Library
Although the role of oncogenic human Alpha‐papillomaviruses (HPVs) in the development
of mucosal carcinomas at different body sites (eg cervix, anus, oropharynx) is fully …
of mucosal carcinomas at different body sites (eg cervix, anus, oropharynx) is fully …
[HTML][HTML] Epidemiology and molecular biology of HPV variants in cervical cancer: the state of the art in Mexico
JO Muñoz-Bello, A Carrillo-García… - International Journal of …, 2022 - mdpi.com
Cervical cancer (CC) continues to be a major public health problem in Mexico, ranking
second among cancers in women. A persistent infection with human papillomaviruses (HPV) …
second among cancers in women. A persistent infection with human papillomaviruses (HPV) …